Gene-Targeted hypertension treatment shows promise for black patients
NCT ID NCT04840342
First seen Nov 06, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study looks at whether a treatment tailored to a specific gene (LSD1) can better control blood pressure and protect the kidneys in Black adults with hypertension. About 300 participants who carry a certain gene variant will follow a controlled diet and receive therapy for 4 weeks. The goal is to find a more effective way to manage high blood pressure in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.